The use of immunotherapies is rapidly expanding across multiple disease areas, increasingly bringing complex immunomodulating treatments into the intensive care setting.
The session will provide an introduction to immunotherapies, outlining key mechanisms of action and current clinical indications relevant to ICU patients. This will be followed by a discussion of common challenges for the intensivist, including recognition and management of immune-related toxicities, diagnostic uncertainty, and coordination with specialty teams.
Based on a real-world, critical care scenario diagnostic and management dilemmas will be highlighted. The session will conclude with an interactive audience discussion to explore practical approaches and shared learning.
×
Dr Victoria Metaxa
Consultant in Critical Care, King's College Hospital
Dr Victoria Metaxa is a full-time Critical Care and Major Trauma Consultant, at King’s College Hospital in London. She is a King's College London Honorary Clinical Senior Lecturer, and has a PhD in neurosciences and an MA in Medical Ethics and Palliative Care from Keele University. Her clinical interests include bioethics, end-of-life care, critical care outreach and the management of patients with haematological malignancies. Dr Metaxa is a member of the European Society of Intensive Care (ESICM) Ethics section, and the representative of the section in the e-learning committee. She is the UK National Outreach Forum board Secretary and a member of the Legal and Ethical Advisory Group of the UK Intensive Care Society (ICS).
